Clinical Trial Update: FOLFIRINOX in Patients With Inoperable Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the FOLFIRINOX regimen in patients with inoperable pancreatic cancer has been terminated; results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• FLUOROURACIL (Fluorouracil)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: University of Oklahoma | Conditions: Adenocarcinoma of Pancreas | Phase 2 | Status: TERMINATED | Results posted: 2018-03-09